Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016Published
8.9KCitations
0References
journal articleType
Journal: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Citations are the number of DOI-registered works in Crossref that cite this paper; references are how many works it cites. Full text is on the publisher site via the DOI link.